Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01.
| Publicado en: | Targeted Oncology Vol. 19; no. 6; pp. 925 - 940 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Nov2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180849443&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 180849443 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17762596 47DQ jtl: Targeted Oncology issn: 17762596 maglogo: N pubinfo: dt: Nov2024 vid: 19 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 180849443 179731841 10.1007/s11523-024-01094-5 180849443 ppf: 925 ppct: 15 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01. aug: au: Hibino, Makoto Imamura, Yoshinori Shimoyama, Rai Fukui, Tomoya Fukai, Ryuta Iwase, Akihiko Tamura, Yukihiro Chihara, Yusuke Okabe, Takafumi Uryu, Kiyoaki Okuda, Tadahisa Taguri, Masataka Minami, Hironobu affil: Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, 1-5-1 Tsujido Kandai, 251-0041, Fujisawa, Kanagawa, Japan sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|